Abstract:Cellular senescence entails an irreversible growth arrest that evolved in part to prevent cancer. Paradoxically, senescent cells secrete proinflammatory and growth-stimulatory molecules, termed the senescence-associated secretory phenotype (SASP), which is correlated with cancer cell proliferation in culture and xenograft models. However, at what tumor stage and how senescence and the SASP act on endogenous tumor growth in vivo is unknown. To understand the role of senescence in cancer etiology, we subjected p16-3MR transgenic mice, which permit the identification and selective elimination of senescent cells in vivo, to the well-established two-step protocol of squamous cell skin carcinoma, in which tumorigenesis is initiated by a carcinogen 7,12-dimethylbenz[α]anthracene, and then promoted by 12-O-tetradecanoyl-phorbol-13-acetate (TPA). We show that TPA promotes skin carcinogenesis by inducing senescence and a SASP. Systemic induction of senescence in nontumor-bearing p16-3MR mice using a chemotherapy followed by the two-step carcinogenesis protocol potentiated the conversion of benign papillomas to carcinomas by elevating p38MAPK and MAPK/ERK signaling. Ablation of senescent cells reduced p38MAPK and MAPK/ERK signaling, thereby preventing the progression of benign papillomas to carcinomas. Thus, we show for the first time that senescent cells are tumor promoters, not tumor initiators, and that they stimulate skin carcinogenesis by elevating p38MAPK and MAPK/ERK signaling. These findings pave the way for developing novel therapeutics against senescence-fueled cancers.Significance:These findings identify chemotherapy-induced senescence as a culprit behind tumor promotion, suggesting that elimination of senescent cells after chemotherapy may reduce occurrence of second cancers decades later.Graphical http://cancerres.aacrjournals.org/content/canres/80/17/3606/F1.large.jpg.

Data from Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA/TPA-Induced Skin Tumor Formation

Data from Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA/TPA-Induced Skin Tumor Formation

Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA/TPA-Induced Skin Tumor Formation

Supplementary Data Fig. 6 from Negative Regulation of P53-Induced Senescence by N-WASP is Crucial for DMBA/TPA-Induced Skin Tumor Formation

Supplementary Data Fig. 5 from Negative Regulation of P53-Induced Senescence by N-WASP is Crucial for DMBA/TPA-Induced Skin Tumor Formation

Supplementary Data Fig. 3 from Negative Regulation of P53-Induced Senescence by N-WASP is Crucial for DMBA/TPA-Induced Skin Tumor Formation

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

WW Domain-containing E3 Ubiquitin Protein Ligase 1 (WWP1) Delays Cellular Senescence by Promoting p27Kip1 Degradation in Human Diploid Fibroblasts

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

Cellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44/42MAPK Signaling

P2RY6 Has a Critical Role in Mouse Skin Carcinogenesis by Regulating the YAP and β-Catenin Signaling Pathways.

Genetic Deletion Of P21(Waf1) Enhances Papilloma Formation But Not Malignant Conversion In Experimental Mouse Skin Carcinogenesis

SENP1 Is a Crucial Regulator for Cell Senescence through DeSUMOylation of Bmi1

REGγ is Critical for Skin Carcinogenesis by Modulating the Wnt/β-catenin Pathway

p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice

Mutant Ras and Inflammation-Driven Skin Tumorigenesis is Suppressed Via a JNK-iASPP-AP1 Axis

P21waf1/cip1 Plays a Critical Role in Modulating Senescence Through Changes of DNA Methylation

Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis

MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner

Elimination of physiological senescent cutaneous cells in a novel p16-dependent senolytic mouse model impacts lipid metabolism in skin aging